Literature DB >> 7510389

Can hammerhead ribozymes be efficient tools to inactivate gene function?

E Bertrand1, R Pictet, T Grange.   

Abstract

In order to improve hammerhead ribozyme efficiency and specificity, we have analyzed, both in vitro and in vivo, the activity of a series of ribozyme/substrate combinations that have the same target sequence but differ in the length of the ribozyme/substrate duplex or in their structure, i.e., the total length of the RNA. In vitro, we have found that optimal kcat/Km (at 37 degrees C) is obtained when the ribozyme/substrate duplex has a length of 12 bases, which according to the base composition represents a calculated free energy of binding of -16 kcal/mol. We discuss the importance of this value for ribozyme specificity and present strategies that may improve it. Increasing the length of the duplex from 14 to 17 bases (from -19 to -26 kcal/mol) produces a reduced ribozyme activity which is probably due to a slower rate of product dissociation. In addition, inclusion of either the substrate or the ribozyme in a long transcript produces a reduction (10 fold) of the kcat/Km, probably because of a different accessibility of the target sequence. In vivo, the activity of the trans-acting ribozyme was extremely low and detected in only one case: with a ribozyme/substrate duplex length of 13 bases and with both ribozyme and substrate embedded in short RNAs expressed at a very high level. The similarity of the results obtained in vitro and in vivo indicates that it is possible to use an in vitro system to optimize ribozymes which are to be used in vivo. Satisfactory results were obtained in vivo only with cisacting ribozymes. Altogether these results suggest that the ribozyme/substrate hybridization step is the limiting step in vivo and therefore it is not clear if ribozymes represent an improvement over antisense RNAs.

Mesh:

Substances:

Year:  1994        PMID: 7510389      PMCID: PMC523579          DOI: 10.1093/nar/22.3.293

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  65 in total

1.  alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition.

Authors:  C Gagnor; J R Bertrand; S Thenet; M Lemaître; F Morvan; B Rayner; C Malvy; B Lebleu; J L Imbach; C Paoletti
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

2.  Simple RNA enzymes with new and highly specific endoribonuclease activities.

Authors:  J Haseloff; W L Gerlach
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

3.  Autolytic processing of a phosphorothioate diester bond.

Authors:  J M Buzayan; P A Feldstein; C Segrelles; G Bruening
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype.

Authors:  H A Ingraham; R P Chen; H J Mangalam; H P Elsholtz; S E Flynn; C R Lin; D M Simmons; L Swanson; M G Rosenfeld
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

6.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

7.  Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

Authors:  B A Sullenger; T R Cech
Journal:  Science       Date:  1993-12-03       Impact factor: 47.728

8.  Production of chimaeric mice containing embryonic stem (ES) cells carrying a homoeobox Hox 1.1 allele mutated by homologous recombination.

Authors:  A Zimmer; P Gruss
Journal:  Nature       Date:  1989-03-09       Impact factor: 49.962

9.  In-vivo secondary structure analysis of the small nuclear RNA U1 using psoralen cross-linking.

Authors:  J P Calvet; J A Myers
Journal:  J Mol Biol       Date:  1987-10-05       Impact factor: 5.469

10.  Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA.

Authors:  A C Prats; L Sarih; C Gabus; S Litvak; G Keith; J L Darlix
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  44 in total

1.  Design of highly specific cytotoxins by using trans-splicing ribozymes.

Authors:  B G Ayre; U Köhler; H M Goodman; J Haseloff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Targeting a KH-domain protein with RNA decoys.

Authors:  Aleksandr V Makeyev; Dawn L Eastmond; Stephen A Liebhaber
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

3.  Optimization of trans-splicing ribozyme efficiency and specificity by in vivo genetic selection.

Authors:  Brian G Ayre; Uwe Köhler; Robert Turgeon; Jim Haseloff
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

4.  Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice.

Authors:  P J L'Huillier; S Soulier; M G Stinnakre; L Lepourry; S R Davis; J C Mercier; J L Vilotte
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

5.  Gene targeting in the Gram-Positive bacterium Lactococcus lactis, using various delta ribozymes.

Authors:  Karine Fiola; Jean-Pierre Perreault; Benoit Cousineau
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 6.  Bottlenecks in development of retinal therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; R Thomas Taggart; Mark C Butler; Tiffany A Kolniak
Journal:  Vision Res       Date:  2007-10-31       Impact factor: 1.886

7.  An alternative approach to synthesize cDNA bypassing traditional reverse transcription.

Authors:  Xiao-Xia Li; Fang Zheng; Yan-Li Jiao; Gang Guo; Bao-Li Wang; Zhi Yao
Journal:  Mol Biotechnol       Date:  2008-01-29       Impact factor: 2.695

8.  Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.

Authors:  M Homann; M Tabler; S Tzortzakaki; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

9.  Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library.

Authors:  A Lieber; M Strauss
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

10.  Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells.

Authors:  R B Denman; M Smedman; W Ju; R Rubenstein; A Potempska; D L Miller
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.